10x Genomics Operating Expenses 2018-2024 | TXG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

10x Genomics operating expenses from 2018 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

10x Genomics operating expenses from 2018 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$11.4B
Inspire Medical Systems (INSP)	$5.9B
Hims & Hers Health (HIMS)	$5B
Axonics (AXNX)	$3.6B
IRhythm Technologies (IRTC)	$2.7B
Enovis (ENOV)	$2.6B
Privia Health (PRVA)	$2.5B
Omnicell (OMCL)	$2.3B
Azenta (AZTA)	$2.2B
Clover Health Investments (CLOV)	$1.7B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.2B
Standard BioTools (LAB)	$800M
Fulgent Genetics (FLGT)	$589M
Butterfly Network (BFLY)	$558M
Talkspace (TALK)	$555M
Definitive Healthcare (DH)	$500M
Health Catalyst (HCAT)	$498M
Pulmonx (LUNG)	$294M
SOPHiA GENETICS SA (SOPH)	$230M
TruBridge (TBRG)	$203M
American Well (AMWL)	$135M
P3 Health Partners (PIII)	$134M
EUDA Health Holdings (EUDA)	$108M
HeartBeam (BEAT)	$68M
Future Health ESG (FHLT)	$65M
111 (YI)	$59M
Zepp Health (ZEPP)	$49M
SHL Telemedicine (SHLT)	$45M
CareCloud (CCLD)	$44M